This study aims to investigate the efficacy and safety of intravascular lithotripsy (IVL) balloon in treating coronary calcified lesions at our center.
Patients with coronary angiography showing vessel diameter stenosis ≥ 70% and moderate to severe calcification;
Reference vessel diameter ≥ 2.5 mm;
Signed informed consent form.
Patients with comorbid conditions such as malignant tumors and an expected lifespan of less than 1 year;
Patients with hemodynamic instability;
Patients classified as New York Heart Association (NYHA) functional class IV;
Any other conditions deemed by the investigator as unsuitable for enrollment.
Patients with coronary Artery disease and moderate to severe coronary artery calcification scheduled for PCI treatment.
Cohort
Prospective
percutaneous coronary intervention
Procedure/SurgeryAll enrolled patients underwent Intravascular Lithotripsy (IVL) and Percutaneous Coronary Intervention (PCI) under guideline-directed management.
MACE: All-Cause Death, Recurrent Myocardial Infarction, Unplanned Target Vessel Revascularization, Acute Stent Thrombosis.
Residual stenosis rate after PCI.
Click on the lead sponsor to view all of their trials.
This trial is not recruiting at the moment. You can still explore other options:
